HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter J Goadsby Selected Research

Peter J Goadsby Research Topics

Disease

197Migraine Disorders (Migraine)
03/2022 - 03/2002
73Headache (Headaches)
03/2022 - 05/2002
43Cluster Headache (Cluster Headaches)
02/2022 - 05/2002
40Pain (Aches)
01/2022 - 01/2003
19Epilepsy (Aura)
01/2022 - 08/2005
12Headache Disorders (Headache Syndromes)
05/2021 - 03/2003
11Primary Headache Disorders
01/2021 - 05/2007
11Nausea
01/2021 - 03/2004
10Migraine with Aura (Familial Hemiplegic Migraine)
01/2022 - 03/2002
6Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania)
01/2021 - 03/2006
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 05/2004
5Ganglion Cysts (Ganglion)
01/2021 - 07/2016
5Hyperacusis (Phonophobia)
01/2021 - 03/2004
5Photophobia (Light Sensitivity)
01/2019 - 03/2004
4visual snow syndrome
01/2022 - 06/2014
4Hyperalgesia
01/2021 - 07/2011
4Secondary Headache Disorders
01/2020 - 08/2006
3Fatigue
01/2021 - 11/2014
3Hypersensitivity (Allergy)
01/2021 - 10/2015
3Erythema
01/2020 - 09/2014
3Prescription Drug Overuse
01/2020 - 03/2010
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2018 - 09/2014
3Vomiting
09/2017 - 11/2014
2Mood Disorders (Mood Disorder)
01/2021 - 02/2012
2Vertigo (Positional Vertigo)
01/2021 - 04/2016
2Nasopharyngitis
01/2020 - 01/2018
2Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

53Calcitonin Gene-Related PeptideIBA
03/2022 - 11/2002
38Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
03/2022 - 03/2004
34Tryptamines (Triptans)IBA
03/2021 - 05/2002
26Monoclonal AntibodiesIBA
01/2022 - 09/2014
17erenumabIBA
01/2022 - 04/2016
15Pharmaceutical PreparationsIBA
05/2021 - 09/2004
15Indomethacin (Indometacin)FDA LinkGeneric
05/2021 - 09/2004
15Serotonin (5 Hydroxytryptamine)IBA
04/2020 - 10/2004
15Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
11/2019 - 08/2004
14Pain-FreeIBA
01/2021 - 01/2004
13galcanezumabIBA
03/2021 - 09/2014
105-HT1F Serotonin ReceptorIBA
02/2022 - 11/2014
10Nitroglycerin (Dynamite)FDA LinkGeneric
01/2022 - 12/2014
10Biological ProductsIBA
01/2021 - 08/2002
8eptinezumabIBA
01/2022 - 11/2014
8fremanezumabIBA
03/2021 - 07/2016
8rimegepant sulfateIBA
01/2021 - 02/2014
8salicylhydroxamic acid (SHAM)IBA
01/2020 - 04/2010
8Dihydroergotamine (Agit)FDA LinkGeneric
07/2017 - 10/2011
7Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
11/2021 - 12/2014
7Sumatriptan (Imigran)FDA LinkGeneric
01/2020 - 10/2004
7Oxygen (Dioxygen)IBA
12/2012 - 10/2004
6ubrogepantIBA
03/2021 - 01/2019
6NeuropeptidesIBA
01/2021 - 03/2010
6Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 10/2002
6Topiramate (Topamax)FDA LinkGeneric
03/2014 - 08/2005
6Vasoconstrictor AgentsIBA
01/2014 - 10/2004
5lasmiditanIBA
02/2022 - 01/2019
5Peptides (Polypeptides)IBA
11/2021 - 12/2014
5Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2008
5Glutamic Acid (Glutamate)FDA Link
01/2021 - 06/2009
4OrexinsIBA
11/2021 - 05/2007
4Analgesics (Analgesic Drugs)IBA
01/2021 - 03/2003
4Acid Sensing Ion ChannelsIBA
01/2021 - 10/2012
4atogepantIBA
01/2021 - 11/2019
4Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 01/2005
4telcagepantIBA
01/2020 - 02/2012
4Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2020 - 12/2014
4Nitric Oxide Synthase (NO Synthase)IBA
11/2014 - 11/2002
4Ion Channels (Ion Channel)IBA
05/2013 - 03/2002
4Verapamil (Calan)FDA LinkGeneric
08/2012 - 04/2004
3Therapeutic UsesIBA
02/2022 - 01/2005
3Type A Botulinum Toxins (Botox)FDA Link
01/2022 - 12/2006
3AntibodiesIBA
01/2021 - 09/2014
3olcegepantIBA
01/2020 - 02/2012
32- (8- (3,5- difluorophenyl)- 10- oxo- 6,9- diazaspiro(4.5)dec- 9- yl)- N- (2'- oxo- 1,1',2',3- tetrahydrospiro(indene- 2,3'- pyrrolo(2,3- b)pyridin)- 5- yl)acetamideIBA
01/2020 - 04/2011
3Lidocaine (Xylocaine)FDA LinkGeneric
01/2018 - 06/2007
3Glutamate Receptors (Glutamate Receptor)IBA
03/2015 - 06/2009
3Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
04/2014 - 03/2002
3Anticonvulsants (Antiepileptic Drugs)IBA
03/2014 - 09/2005
3TRPV1 receptorIBA
11/2012 - 11/2007
3Dopamine (Intropin)FDA LinkGeneric
06/2010 - 03/2007
3zolmitriptan (Zomig)FDA Link
10/2009 - 01/2006
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2008 - 04/2003
2Illicit Drugs (Recreational Drugs)IBA
01/2022 - 05/2014
2Insulin (Novolin)FDA Link
11/2021 - 05/2017
2LeptinIBA
11/2021 - 05/2017
2Glucagon (Glukagon)FDA Link
11/2021 - 05/2017
2Neuropeptide YIBA
11/2021 - 01/2016
2Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 - 06/2005
2Memantine (Namenda)FDA Link
01/2021 - 01/2019
2frovatriptan (Allegro)FDA Link
01/2021 - 09/2017
2Hallucinogens (Psychedelics)IBA
11/2020 - 05/2014
2Opioid Analgesics (Opioids)IBA
01/2020 - 01/2018
2Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
01/2020 - 10/2015

Therapy/Procedure

76Therapeutics
02/2022 - 09/2004
12Vagus Nerve Stimulation
01/2021 - 03/2015
10Transcranial Magnetic Stimulation
01/2021 - 04/2010
5Aftercare (After-Treatment)
01/2020 - 12/2009
3Contraindications
01/2021 - 09/2010
3Drug Therapy (Chemotherapy)
11/2019 - 06/2009
3Injections
09/2019 - 02/2014
3Deep Brain Stimulation
06/2012 - 02/2008